Baylor College of Medicine

Study on COVID-19 Systemic Allergic Reactions To SARS-COV-2 Vaccination (H-49356)

Description

Content

The study is designed with two principal aims: First, to estimate the proportions of systemic allergic reactions to the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine in a high-allergy/mast cell disorder (HA/MCD) population. Second, if the risk in the HA/MCD is demonstrable, to determine whether the proportions are higher in the HA/MCD versus a comparison population.

Contact

Sherilyn Pillack, RN

Phone 1: 713–798–7525

IRB: H-49356

Status:

Active

Created:

Back to topback-to-top